BGMS - Cyclacel Pharmaceuticals, Inc.

QQQ $ 629.78 $ -3.11 (-0.49 %)

DIA $ 472.70 $ -2.66 (-0.56 %)

SPY $ 681.88 $ -2.29 (-0.33 %)

TLT $ 89.68 $ 0.07 (0.08 %)

GLD $ 366.72 $ 0.05 (0.01 %)

Previous Close

$ 5.05

Open

$ 5.35

Bid

$ 4.70 x 425

Ask

$ 5.70 x 200

Day's Range

-- - --

52 Week Range

$ 3.10 - $ 16.00

Volume

6,463

Average Volume

Market Cap

4.16M

Beta (5Y Monthly)

$ 0.48

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	04-02-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	03-21-2024	12-31-2023	10-K
8	11-29-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-08-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-30-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-14-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-13-2020	06-30-2020	10-Q
22	05-12-2020	03-31-2020	10-Q
23	03-05-2020	12-31-2019	10-K
24	11-13-2019	09-30-2019	10-Q
25	08-13-2019	06-30-2019	10-Q
26	05-14-2019	03-31-2019	10-Q
27	03-28-2019	12-31-2018	10-K
28	11-13-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-14-2018	03-31-2018	10-Q
31	03-30-2018	12-31-2017	10-K
32	11-13-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-12-2017	03-31-2017	10-Q
35	03-31-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-11-2016	06-30-2016	10-Q
38	05-13-2016	03-31-2016	10-Q
39	03-29-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Monday's P...
09/08/2025 12:08:53

12 Health Care Stocks Moving In Thursday's...
07/24/2025 12:08:09

Reported Earlier: Cyclacel Pharmaceuticals...
07/07/2025 15:58:09

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, "Cyclacel" or the "Company"))), a biopharmaceutical ...

Trading Halt: Halt status updated at 9:00:...
07/07/2025 13:00:06

12 Health Care Stocks Moving In Wednesday'...
06/04/2025 17:08:33

12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 21:05:58

Trading Halt: Halt status updated at 9:00:...
05/12/2025 13:00:06

Trading Halt: Halted at 7:50:00 p.m. ET - ...
05/09/2025 23:50:04

Cyclacel Pharmaceuticals Enters Exchange A...
05/06/2025 10:20:57

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, "Cyclacel" or the "Company"))) today announced that ...

Cyclacel Pharmaceuticals Announces Leaders...
02/27/2025 18:43:14

Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ:CYCC, NASDAQ:CYCCP), a biopharmaceutical company that develops inno...

Cyclacel Pharmaceuticals Announces Its Exp...
12/05/2024 21:40:21

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", ))), a biopharmace...

Cyclacel Pharmaceuticals Announces Exercis...
11/13/2024 17:24:49

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", ))), a biopharmace...

Cyclacel Pharmaceuticals To Present New Cl...
10/09/2024 13:17:37

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", )))), a biopharmac...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
10/04/2024 16:32:35

Cyclacel's Fadraciclib Reports Efficacy In...
06/04/2024 12:27:03

- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action -BERKELEY HEIGH...

Cyclacel Pharmaceuticals To Present Clinic...
06/03/2024 12:38:57

- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study i...

12 Health Care Stocks Moving In Friday's I...
04/12/2024 16:31:01

Cyclacel Pharmaceuticals To Present New Cl...
04/01/2024 13:16:41

- New clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing development program ...

Cyclacel Pharmaceuticals Announces Preclin...
03/07/2024 14:24:48

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", )))), a biopharmac...

Cyclacel Pharmaceuticals Announces Receipt...
03/06/2024 14:25:40

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", )))), a biopharmac...

CYCCP Cyclacel Pharmaceuticals, Inc.

Nasdaq cyclacel.com

$ 5.04 $ -0.23 (-4.36 %)

Thursday, 11-Sep-2025 15:01:44 EDT

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Search Symbol

Create a Free Account Sign in to your Account Reset Password

CYCCP Cyclacel Pharmaceuticals, Inc.

Nasdaq cyclacel.com

$ 5.04 $ -0.23 (-4.36 %)

Thursday, 11-Sep-2025 15:01:44 EDT

Create a Free Account Sign in to your Account Reset Password

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Add/Delete Symbol to your Portfolio